Mind Medicine Inc [MNMD] stock prices are up 7.10% to $7.69 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MNMD shares have gain 12.43% over the last week, with a monthly amount glided 2.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mind Medicine Inc [NASDAQ: MNMD] stock has seen the most recent analyst activity on December 20, 2024, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $20. On July 24, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $36 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $27 on May 29, 2024. Leerink Partners initiated its recommendation with a Outperform and recommended $20 as its price target on April 15, 2024. Canaccord Genuity started tracking with a Buy rating for this stock on December 05, 2023, and assigned it a price target of $9.
The stock price of Mind Medicine Inc [MNMD] has been fluctuating between $3.49 and $12.22 over the past year. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Mind Medicine Inc [NASDAQ: MNMD] shares were valued at $7.69 at the most recent close of the market. An investor can expect a potential return of 82.05% based on the average MNMD price forecast.
Analyzing the MNMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -19.36%, Pretax Profit Margin comes in at -20.22%, and Net Profit Margin reading is -20.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.53 and Total Capital is -0.33. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.29 points at the first support level, and at 6.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.96, and for the 2nd resistance point, it is at 8.23.
Ratios To Look Out For
It’s worth pointing out that Mind Medicine Inc [NASDAQ:MNMD]’s Current Ratio is 9.00. In addition, the Quick Ratio stands at 9.00 and the Cash Ratio stands at 8.88.
Transactions by insiders
Recent insider trading involved Barrow Robert, Chief Executive Officer, that happened on Dec 26 ’24 when 19106.0 shares were sold. Chief Accounting Officer, Liao Carrie completed a deal on Dec 26 ’24 to sell 2273.0 shares. Meanwhile, Chief Medical Officer Karlin Dan sold 6643.0 shares on Dec 26 ’24.
